Author Correction: Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity.
Sant'Anna R, Gallego P, Robinson LZ, Pereira-Henriques A, Ferreira N, Pinheiro F, Esperante S, Pallares I, Huertas O, Almeida MR, Reixach N, Insa R, Velazquez-Campoy A, Reverter D, Reig N, Ventura S.
Sant'Anna R, et al.
Nat Commun. 2023 Feb 3;14(1):582. doi: 10.1038/s41467-023-36239-z.
Nat Commun. 2023.
PMID: 36737445
Free PMC article.
No abstract available.